Nectar Lifesciences share price
You have to be logged in to add this to Watchlist.- ₹12.60(0.24%)May 15, 2026 15:29:19 PM IST
- NSE
- BSE
- Vol : 78.02 K (NSE + BSE)Last 20 day avg : 497.92 K
Nectar Lifesciences is trading 0.24% upper at Rs 12.60 as compared to its last closing price. Nectar Lifesciences has been trading in the price range of 12.94 & 12.60. Nectar Lifesciences has given -34.31% in this year & -5.97% in the last 5 days. The company posted a net profit of 14.27 Crores in its last quarter.Listed peers of Nectar Lifesciences include Cipla (-0.49%), Torrent Pharmaceuticals (-0.52%), Dr Reddy's Laboratories (2.62%).The Mutual Fund holding in Nectar Lifesciences was at -% in . The MF holding has - from the last quarter. The FII holding in Nectar Lifesciences was at 0.60% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 16, 2026, 06:38 PM UTC
- BetaHigh volatility1.34Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.61The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Cipla | Moderately Bullish | 1,431.55 | -0.49 | 1,16,013.10 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 4,386.00 | -0.52 | 1,48,148.92 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Bullish | 1,336.95 | 2.62 | 1,11,584.24 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Bullish | 6,755.00 | -2.41 | 1,78,679.99 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,879.90 | 0.90 | 4,51,076.67 | 36.24 | 5.77 | 0.92 | 0.50 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-23 | Quarterly Results & Others |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results & Others |
| 2025-07-23 | Others |
| 2025-07-07 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE023H01027
- BSE Code532649
- NSE CodeNECLIFE
Nectar Lifesciences is trading at 12.60 as on Fri May 15 2026 09:59:19. This is 0.24% upper as compared to its previous closing price of 12.57.
The market capitalization of Nectar Lifesciences is 245.95 Cr as on Fri May 15 2026 09:59:19.
The 52 wk high for Nectar Lifesciences is 28.27 whereas the 52 wk low is 9.20
Nectar Lifesciences can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 24.31
- Dividend Yield: 0.00%
- D/E ratio: -
Nectar Lifesciences reported a net profit of -113.68 Cr in 2025.
EQUITY QUICK LINKS
Nectar Lifesciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.